These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 580297)

  • 1. Lymphocele. A complication of cancer chemotherapy.
    Jones WB; Rhamy RK; Faber RB; Flexner JM; Molin JA
    JAMA; 1978 Apr; 239(14):1419-20. PubMed ID: 580297
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of combined chemotherapy of lymphosarcoma with cyclophosphamide, vincristine and prednisolone].
    Abdyldaev RA; Kruglova GV
    Vopr Onkol; 1983; 29(4):83-5. PubMed ID: 6687966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recently recognized complications of cancer chemotherapy.
    Arseneau JC; Canellos GP; DeVita VT; Sherins RJ
    Ann N Y Acad Sci; 1974; 230():481-8. PubMed ID: 4595953
    [No Abstract]   [Full Text] [Related]  

  • 4. Cyclic chemotherapy in lymphoma.
    Mukherji B; Oettgen HF; Yagoda A; Krakoff IH
    Cancer; 1971 Oct; 28(4):886-93. PubMed ID: 4939250
    [No Abstract]   [Full Text] [Related]  

  • 5. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincristine, and prednisone.
    Bagley CM; Devita VT; Berard CW; Canellos GP
    Ann Intern Med; 1972 Feb; 76(2):227-34. PubMed ID: 5066691
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy of advanced lymphocytic lymphoma. Importance of histologic classification in evaluating response.
    Skarin AT; Pinkus GS; Myerowitz RL; Bishop YM; Moloney WC
    Cancer; 1974 Oct; 34(4):1023-9. PubMed ID: 4608354
    [No Abstract]   [Full Text] [Related]  

  • 7. Retroperitoneal fibrosis after chemotherapy.
    Fassina A; Boscolo Berto R; El Mazloum R; Gottardo F; Artibani W
    Eur Urol; 2007 Jan; 51(1):270-1; quiz 272. PubMed ID: 16632190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
    Comella P; Abate G; Fiore M; Di Finizio G; Zarrilli D
    J Chemother; 1989 Jul; 1(4 Suppl):1257-8. PubMed ID: 16312856
    [No Abstract]   [Full Text] [Related]  

  • 9. A comparison of cyclophosphamide, vincristine, and prednisone (COP) with nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) in the treatment of nodular, poorly differentiated, lymphocytic lymphoma.
    Benjamin RS; Wiernik PH; O'Connell MJ; Chang P; Sutherland JC
    Cancer; 1976 Nov; 38(5):1896-902. PubMed ID: 1036467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alveolitis during procarbazine, vincristine and cyclophosphamide therapy.
    Dohner VA; Ward HP; Standord RE
    Chest; 1972 Nov; 62(5):636-9. PubMed ID: 4678041
    [No Abstract]   [Full Text] [Related]  

  • 11. [Supportive care for patients with non-Hodgkin lymphoma receiving R-CHOP chemotherapy].
    Kato H
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():636-41. PubMed ID: 25831838
    [No Abstract]   [Full Text] [Related]  

  • 12. Combination chemotherapy of lymphomas other than Hodgkin's disease.
    Stein RS; Moran EM; Desser RK; Miller JB; Golomb HM; Ultmann JE
    Ann Intern Med; 1974 Nov; 81(5):601-8. PubMed ID: 4608355
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined cyclophosphamide vincristine, and prednisone therapy of malignant lymphoma.
    Luce JK; Gamble JF; Wilson HE; Monto RW; Isaacs BL; Palmer RL; Coltman CA; Hewlett JS; Gehan EA; Frei E
    Cancer; 1971 Aug; 28(2):306-17. PubMed ID: 4935774
    [No Abstract]   [Full Text] [Related]  

  • 14. Hydroxyldaunomycin (Adriamycin) combination chemotherapy in malignant lymphoma.
    McKelvey EM; Gottlieb JA; Wilson HE; Haut A; Talley RW; Stephens R; Lane M; Gamble JF; Jones SE; Grozea PN; Gutterman J; Coltman C; Moon TE
    Cancer; 1976 Oct; 38(4):1484-93. PubMed ID: 791473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of histologic subtype on toxicity and response to chemotherapy in non-hodgkin's lymphoma. An Eastern Cooperative Oncology Group Study utilizing the BCVP regimen.
    Oken MM; Costello WG; Johnson GJ; Lenhard RE; Ezdinli EZ; Orlow E; Barnes JM; Berard CW; Glick JH
    Cancer; 1983 May; 51(9):1581-6. PubMed ID: 6339028
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.
    Visani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; Malerba L; Isidori A; Malagola M; Piccaluga PP
    Leuk Lymphoma; 2005 Mar; 46(3):477-9. PubMed ID: 15621843
    [No Abstract]   [Full Text] [Related]  

  • 17. Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma.
    Lowenbraun S; DeVita VT; Serpick AA
    Cancer; 1970 May; 25(5):1018-25. PubMed ID: 4910254
    [No Abstract]   [Full Text] [Related]  

  • 18. Pulmonary nocardiosis complicating malignant lymphoma successfully treated with chemotherapy.
    Pinkhas J; Oliver I; De Vries A; Spitzer SA; Henig E
    Chest; 1973 Mar; 63(3):367-70. PubMed ID: 4570572
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of irreversible chemotherapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy.
    Blumenfeld Z; Avivi I; Linn S; Epelbaum R; Ben-Shahar M; Haim N
    Hum Reprod; 1996 Aug; 11(8):1620-6. PubMed ID: 8921104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Interstitial pneumonia in patients treated with VACOP-B therapy for malignant lymphoma].
    Sakai C; Goto S; Nakaseko C; Kumagai K; Takagi T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):423-6. PubMed ID: 9492839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.